Predicting IgG Levels in Mild COVID-19 Patients
Author Information
Author(s): Yi Jianying, Liu Zhili, Cao Xi, Pi Lili, Zhou Chunlei, Mu Hong
Primary Institution: Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
Hypothesis
What factors influence serum immunoglobulin G (IgG) levels in asymptomatic and mild COVID-19 patients?
Conclusion
Younger age, lower IL-6 levels, vaccination status, and absence of comorbidities are key predictors of higher serum IgG levels in mild COVID-19 patients.
Supporting Evidence
- Mild patients had higher IgG levels than asymptomatic patients.
- Receiving three or more doses of the COVID-19 vaccine was the most beneficial factor for elevated serum IgG levels.
- Serum IgG was positively correlated with serum IgM and negatively correlated with age, PCT, IL-6, and BMI.
Takeaway
This study helps doctors understand how to predict antibody levels in people with mild COVID-19, which can help them make better treatment decisions.
Methodology
A retrospective analysis of data from 1939 COVID-19 patients was conducted, using logistic regression and ROC curves to identify predictors of serum IgG levels.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the single-center design.
Limitations
The study is a single-center retrospective analysis with limited variables and lacks specific cellular immune response data.
Participant Demographics
The study included 1,939 patients, with 1,549 asymptomatic and 390 mild cases, predominantly male among asymptomatic patients and female among mild cases.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website